Multipotent Mesenchymal Stem Cell Treatment for Discogenic Low Back Pain and Disc Degeneration
Low back pain with resultant loss of function, decreased productivity, and high economic costs is burdensome for both the individual and the society. Evidence suggests that intervertebral disc pathology is a major contributor to spine-related pain and degeneration. When commonly used conservative th...
Saved in:
Main Authors: | Jeffrey Zeckser (Author), Michael Wolff (Author), Jason Tucker (Author), Josh Goodwin (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paraspinal muscle hypotrophy and chronic discogenic low back pain
by: Truszczyńska-Baszak Aleksandra, et al.
Published: (2018) -
Wogonin, a Bioactive Ingredient from Huangqi Guizhi Formula, Alleviates Discogenic Low Back Pain via Suppressing the Overexpressed NGF in Intervertebral Discs
by: Jitian Li, et al.
Published: (2023) -
Etiology and nature of intervertebral disc degeneration and its correlation with low back pain
by: Koji Koyama, et al.
Published: (2015) -
Mesenchymal Stem Cell for Prevention and Management of Intervertebral Disc Degeneration
by: Umile Giuseppe Longo, et al.
Published: (2012) -
Office-based Exercise Therapy as a Non-pharmacological Treatment for Discogenic Low Back Pain among Army Staff
by: Reza ALIZADEH, et al.
Published: (2018)